Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocept Inc (NQ: BIOC )

4.794 USD +0.214 (+4.67%)
Streaming Delayed Price Updated: 12:44 PM EST, Dec 2, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 286,011
Open 4.610
Bid (Size) 4.790 (5)
Ask (Size) 4.800 (2)
Prev. Close 4.580
Today's Range 4.520 - 4.800
52wk Range 0.2100 - 6.350
Shares Outstanding 68,213,349
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately
Healthcare design innovation firm known for its 'hospital in a box' solution expands modular offerings with new MedModLabs initiative, first rolling out in Philadelphia to help address Pennsylvania's... 
From PR Newswire
Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central N
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve... 
From PR Newswire

Performance

YTD
+1269.63%
+1269.63%
1 Month
+10.20%
+10.20%
3 Month
+649.02%
+649.02%
6 Month
+1046.82%
+1046.82%
1 Year
+809.45%
+809.45%

More News

Read More
Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®
From PR Newswire
Biocept Reports Third Quarter 2020 Financial Results
From PR Newswire
Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received
From PR Newswire
Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells
From PR Newswire
Biocept Awarded Broad Japanese Patent for the Use of Binding Entities in Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any Sample Type
From PR Newswire
Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020
From PR Newswire
Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received
From PR Newswire
12 Healthcare Stocks Moving In Friday's Intraday Session
Tags Market News ARPO CYCN
From Benzinga
12 Healthcare Stocks Moving In Friday's Pre-Market Session
Tags IMAC Pre/Market Outlook Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.